fbpx Scientist - Population Genomics in Seattle, WA for Variant Bio
Job Seekers, Welcome to GSA Job Board
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 37 Jobs
Save Agent
Loading... Please wait.
University of Missouri

Columbia, Missouri

NEW! NEW!
Harvard Medical School

Boston, Massachusetts

Stanford University Logo
Stanford University

Stanford , California

Pennsylvania State University Logo
Pennsylvania State University

University Park, Pennsylvania

University of Florida

Gainesville, Florida

University of Florida

Gainesville, Florida

Villanova University

Villanova, Pennsylvania

National Cancer Institute (NCI), National Institutes of Health (NIH)

Frederick, Maryland

Loma Linda University Faculty Medical Group Logo
Loma Linda University Faculty Medical Group

Loma Linda, California

Stowers Institute for Medical Research Logo
Stowers Institute for Medical Research

Kansas City, Missouri

Boris A. Leibovitch

New York, New York

NYU Grossman School of Medicine

New York, New York

National Institutes of Health Logo
National Institutes of Health

Bethesda, Maryland

UC Davis Health

Sacramento, California

University of California Los Angeles

Los Angeles, California

University of California Los Angeles

Los Angeles, California

Fred Hutchinson Cancer Center Logo
Fred Hutchinson Cancer Center

Seattle, Washington

Midwestern University

Glendale, Arizona

U.S Food and Drug Administration, Center for Devices and Radiological Health Logo
U.S Food and Drug Administration, Center for Devices and Radiological Health

Silver Spring, Maryland

The Permanente Medical Group, Inc. (Kaiser Permanente Northern California)

Modesto & Oakland, California

University Hospitals Cleveland Medical Center

Cleveland, Ohio

Medical College of Wisconsin Logo
Medical College of Wisconsin

Wisconsin

Loading... Please wait.
Scientist - Population Genomics
Variant Bio is a Seattle-based biotech company entering a rapid growth stage having recently closed a $100mm+ Series B. The company was started because we believe that human genetics has the power to transform drug development. We are working towards developing therapies to improve global health by studying the genes of people who are outliers for medically relevant traits. To facilitate this, we have built proprietary genomics and phenotyping platforms that allow us to dramatically reduce the cost of genomic studies and identify genetically-validated targets for therapeutic development. All of our studies are co-design


This job listing is no longer active.

Check the left side of the screen for similar opportunities.
Loading. Please wait.
Powered By Naylor Association Solutions


Footer